Verici DX (VRCI) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 Apr 2023 07:00 AM
RNS
Final results timing
24 Apr 2023 07:00 AM
RNS
Final results timing
28 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
28 Mar 2023 11:00 AM
RNS
Price Monitoring Extension
28 Mar 2023 09:05 AM
RNS
Second Price Monitoring Extn
28 Mar 2023 09:00 AM
RNS
Price Monitoring Extension
27 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
27 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
27 Mar 2023 11:00 AM
RNS
Price Monitoring Extension
22 Mar 2023 07:00 AM
RNS
Operational Update
21 Mar 2023 04:40 PM
RNS
Second Price Monitoring Extn
21 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
13 Mar 2023 07:00 AM
RNS
Statement re. Silicon Valley Bank
09 Mar 2023 07:00 AM
RNS
Two key patents granted in the US
02 Mar 2023 07:00 AM
RNS
CLIA Certificate of Compliance
27 Feb 2023 02:00 PM
RNS
Price Monitoring Extension
07 Dec 2022 07:00 AM
RNS
Director/PDMR Shareholding
01 Dec 2022 06:07 PM
RNS
Correction: Holding(s) in Company
03 Oct 2022 07:00 AM
RNS
Product rebranding as TutiviaT
07 Sep 2022 07:00 AM
RNS
Half-year Report
06 Sep 2022 07:00 AM
RNS
Positive results for Clarava from validation study
05 Sep 2022 07:00 AM
RNS
Notice of Results
02 Sep 2022 04:41 PM
RNS
Second Price Monitoring Extn
02 Sep 2022 04:35 PM
RNS
Price Monitoring Extension
27 Jun 2022 03:17 PM
RNS
Result of AGM and voting results
24 Jun 2022 07:00 AM
RNS
Holding(s) in Company
20 Jun 2022 07:30 AM
RNS
Distribution of Verici Dx shares by EKF
16 Jun 2022 07:00 AM
RNS
Investor Presentation
15 Jun 2022 10:57 AM
RNS
CEO Video Interview
14 Jun 2022 09:00 AM
RNS
Further data from TutevaT validation study
09 Jun 2022 07:00 AM
RNS
Commercial Team Appointments
25 May 2022 12:00 PM
RNS
Posting of Annual Report & Accounts
19 May 2022 07:00 AM
RNS
Final Results
12 May 2022 07:00 AM
RNS
Results of TutevaT clinical validation study
01 Apr 2022 07:00 AM
RNS
Clinical Validation Study Update
23 Mar 2022 06:12 PM
RNS
Holding(s) in Company
21 Mar 2022 07:00 AM
RNS
Holding(s) in Company
18 Mar 2022 05:13 PM
RNS
Holding(s) in Company
16 Mar 2022 03:33 PM
RNS
Holding(s) in Company
15 Mar 2022 04:34 PM
RNS
Holding(s) in Company
11 Mar 2022 09:30 AM
RNS
Close of Subscription and Fundraise Update
04 Mar 2022 04:13 PM
RNS
Result of Fundraise
04 Mar 2022 12:20 PM
RNS
Close of Accelerated Bookbuild
04 Mar 2022 07:10 AM
RNS
Proposed Fundraise
15 Feb 2022 07:00 AM
RNS
Successful completion of analytical validation
14 Jan 2022 07:00 AM
RNS
Investor Presentation
12 Jan 2022 02:00 PM
RNS
Progress and strategy update
06 Jan 2022 07:00 AM
RNS
ClaravaT and TutevaT complete testing requirements
05 Jan 2022 07:00 AM
RNS
Collaboration with Illumina
04 Jan 2022 07:00 AM
RNS
Grant of two CPT Codes by AMA

Verici Dx is an immuno-diagnostics company that produces advanced clinical tests and organ transplant platforms for kidney transplant patients.

Verici Dx share price is listed in London under the ticker VRCI.

UK 100

Latest directors dealings